miR-193: It has been previously described that miR-193 directly targets the insulin-like growth factor-1 receptor (IGF1R), and its overexpression inhibits PASMC proliferation in pulmonary hypertension. This evidence concerns the gene IGF1R and pulmonary arterial hypertension.